Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Rekvina Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 5.05 0.00  | 0.00% - - 3.04
BSE Price: Dec 05, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Dec 05, 2019 5.05 0.00 0.00% 5.05 5.05 51 5.05 - 5.05
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
GET STOCK UPDATES FROM VALUE RESEARCH IN YOUR INBOX
6M Average Volume: 51 P/B: 20.34 NSE Code:
52-Week Range: R 5.00 - 5.55 Dividend Yield: 0.00% BSE Code: 526075
TTM EPS: R -0.37 Book Value: R 0.25 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 37
Price Graph
  • Procter & Gamble Health (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Value Research Stock Advisor now has 37 stock recommendations and new ones are added every month.
Thousands of our members are using the current market conditions to buy great stocks at low prices.

Membership of this premium service is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Rekvina Laboratories - - - - -11.53 -19.55 -
S&P BSE Small Cap* -8.51 -0.49 7.68 -6.16 3.56 3.23 5.53
S&P BSE Healthcare* -3.24 2.16 4.31 -2.91 -4.93 -2.03 10.33
Company's return has been calculated on basis of BSE's price.
As on Dec 06, 2019
*As on Dec 05, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue - - -
Net Profit -314.17 -371.31 -236.36
EPS -313.91 -371.75 -236.35
Book Value -16.45 -10.26 -9.24
Average
Unable to fetch data.
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue - - -
Operating Profit 88.89 80.00 98.31
Net Profit 88.89 80.00 98.31
EPS 88.59 79.52 98.26
TTM
Revenue - -100.00 -100.00
Operating Profit 1.78 -142.86 -187.01
Net Profit 1.78 -142.86 -187.01
EPS 1.77 -142.78 -186.85
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Rekvina Laboratories 3.04 0.00 -0.22 -2,009.09 -17.92 20.34 -
Astrazeneca Pharma India 6,631.63 818.54 74.85 8.97 20.03 20.12 88.60
Procter & Gamble Health 7,064.70 894.23 835.89 14.21 73.79 9.06 52.71
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jun 26, 2018 Amit Shah  Buy Market 90,607 5.23 4.74
Jun 26, 2018 Mukesh Shah  Buy Market 109,593 5.23 5.73
Jun 26, 2018 Surbhit Shah  Buy Market 90,207 5.23 4.72
Jun 26, 2018 Surbit Shah  Buy Market 90,207 5.23 4.72
Jun 29, 2016 Amit Mukeshbhai Shah/Surbhit Mukeshbhai Shah  Buy Market 122,000 3.99 4.87
News & Announcements
Contact Information

Company: Rekvina Laboratories Ltd.

Address: Paradise Complex, 328 - 329, 3rd Floor , Sayajigunj, Vadodara, Gujarat - 390005 | Phone: 0265 2362966

Email: [email protected]

Registrar & Transfer Agent: Purva Shareregistry (India) Pvt Ltd

Address: Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg, Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E]

Essential checks
Altman Z-Score
-0.59
Piotroski F-Score
2
Modified C-Score
3
5-Years Price to Earnings
Not applicable
5-Years Price to Book
20.34
Earnings Yield
EBIT / Enterprise value
-7.12%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,652.10 -2.42%
Eris Lifesciences R476.35 +7.39%
FDC R206.25 +4.14%
Granules India R121.50 -4.44%
JB Chemicals & Pharma R403.25 +0.41%
Laurus Labs R340.20 -1.05%
Procter & Gamble Health R4,255.45 -1.09%
Strides Pharma Science R378.05 -0.49%
Sun Pharma Adv. Research R153.80 -1.51%
Suven Life Sciences R279.55 +2.46%
As on Dec 06, 15:59